Home›Companies›Healthcare›EyeMac Regen

EyeMacular Regeneration, Inc.

Develops surgical instruments for patients with advanced macular disease.

No LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 25, 2026·Suggest an edit

About EyeMac Regen

EyeMac Regen is a private company based in St. Paul, Minnesota, incorporated in 2023 in Delaware. It has reported $2,870,000 raised in one offering on Form D since October 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 8, 2024Oct 24, 2024amended Sep 25, 2026$2,870,000of $6.0M target14$205KEquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EyeMac Regen's Form D filed Sep 25, 2026.

DH
David Herman
Director
MO
VO
Virginia Olsen
Secretary and Chief Human Capital Officer
TO
Timothy Olsen
Executive officer and director
GB
DB
David Brown
Director

Sources

  1. SECEyeMacular Regeneration, Inc. Form D/A, filed Oct 9, 2025
  2. SECEyeMacular Regeneration, Inc. Form D, filed Oct 24, 2024
  3. SECEyeMacular Regeneration, Inc. filing history